Blog | BioInformant

Top Companies Developing Cell Therapy Treatments For Diabetes in 2026

July 30, 2026 By Cade Hildreth, Founder & President 7 Comments

Below is a list of the top companies exploring cell therapy treatments for diabetes. [Read more…]

Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel

July 27, 2026 By BioInformant Team Leave a Comment

New agreement secures flexible and scalable manufacturing to support the U.S. commercial and global clinical supply of miv-cel

EMERYVILLE, Calif., and WALTHAM, Mass., July 27, 2026 — Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company developing cell therapies for patients with autoimmune diseases, and ElevateBio, a technology-driven advanced therapy contract development and manufacturing organization (CDMO), today announced a manufacturing agreement for both U.S. commercial and global clinical supply of miv-cel (mivocabtagene autoleucel), Kyverna’s autologous CD19-directed CAR T-cell therapy. [Read more…]

Longevity Medical Institute® Launches Advanced Intranasal Regenerative Neurological Therapy Platform

July 23, 2026 By BioInformant Team Leave a Comment

Non-invasive nose-to-brain delivery system expands treatment options for patients with neurological disorders as an alternative to intrathecal administration.

SAN JOSé DEL CABO, BAJA CALIFORNIA SUR, MEXICO, July 23, 2026 — Longevity Medical Institute^® today announced the launch of its Regenerative Neurological Therapy Program, featuring an advanced intranasal delivery platform designed to transport regenerative therapies toward the brain through the nasal cavity. The technology expands the institute’s comprehensive neurological program by offering patients a non-invasive alternative to intrathecal administration for selected neurological conditions.
[Read more…]

STAT6 as a Diagnostic Marker in Solitary Fibrous Tumors and Soft Tissue Neoplasms

July 20, 2026 By Cade Hildreth, Founder & President Leave a Comment

Accurate tumor classification guides diagnosis, prognosis, and treatment decisions. This is particularly essential when morphologically similar tumors arise from different tissue lineages. STAT6 (signal transducer and activator of transcription 6) has emerged as a valuable diagnostic marker, as its expression pattern can help distinguish specific mesenchymal neoplasms from their histologic mimics. [Read more…]

Guide To The Stem Cell Donation Process

July 18, 2026 By BioInformant Team Leave a Comment

Stem cell donation can be an overwhelming topic for those considering it. However, the procedure itself is often simple to undergo. Here are the key aspects associated with the the stem cell donation process. [Read more…]